V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002670 | 240005314 | 1.69 | 106.2 | null | null | 2018-03-14 | AML MyeChild | null | null | CLADRIBINE | 100949403 |
| 240002672 | 240005315 | 1.83 | 11.75 | Curative (C) | 2018-06-09 | 2018-07-01 | DA 3+8 | 01 | N | MELPHALAN | 101739125 |
| 240002674 | 240005316 | 1.5 | 64.4 | Curative (C) | 2018-03-28 | 2018-03-29 | null | 02 | N | IMATINIB | 101640580 |
| 240002676 | 240005317 | 1.68 | 88.8 | 03 | 2019-06-13 | 2019-06-28 | NHL Inter B NHL ritu 2010 C CYVE1,2 | 2 | N | TRIAL | 101764303 |
| 240002681 | 240005321 | 1.73 | 59 | 03 | null | 2017-02-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101392613 |
| 240002683 | 240005323 | 1.77 | 72.2 | null | null | 2016-08-31 | null | null | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101346341 |
| 240002684 | 240005324 | 1.58 | 85.5 | Curative (C) | 2017-01-07 | 2017-01-21 | TRANSPLANT ATG + FLUDARABINE + THIOTEPA + TREOSULFAN | 02 | null | CHLORAMBUCIL | 100457332 |
| 240002685 | 240005325 | 1.86 | 81.4 | Curative (C) | 2019-02-01 | 2019-02-14 | FLAG + Idarubicin | 02 | N | AML MYECHILD 01 IT CYT | 100765527 |
| 240002686 | 240005326 | 1.61 | 45 | null | 2021-07-21 | 2021-07-23 | Bortezomib + Thalidomide +/- Dex | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100504024 |
| 240002687 | 240005327 | 0 | 35 | 03 | 2018-09-15 | 2018-10-06 | Midostaurin | 01 | N | NOT MATCHED | 101805483 |
| 240002688 | 240005328 | null | null | Curative (C) | null | 2018-10-21 | CHLORAMBUCIL + RITUXIMAB | null | null | IBRUTINIB | 100782832 |
| 240002689 | 240005329 | 1.54 | 21.65 | Palliative (P) | null | 2019-04-13 | Methotrexate intrathecal | 02 | null | IVOSIDENIB | 101438199 |
| 240002690 | 240005330 | 1.59 | 50.6 | null | 2020-02-09 | 2020-02-09 | null | 01 | null | CYTARABINE + DAUNORUBICIN | 100728299 |
| 240002691 | 240005331 | 1.71 | 107.9 | Palliative (P) | 2018-02-23 | 2018-03-02 | Etoposide PBSCT Mobilisat (1.6g/m2) | 02 | N | CLADRIBINE | 101090800 |
| 240002692 | 240005332 | 1.8 | 63.1 | Curative (C) | 2017-05-28 | 2017-06-18 | R CODOX M | 02 | N | CHLORAMBUCIL | 101690729 |
| 240002694 | 240005333 | 1.61 | 98.7 | null | null | 2019-08-02 | Chlorambucil | N | null | LENALIDOMIDE | 100890404 |
| 240002695 | 240005334 | 1.76 | 64.8 | 03 | null | 2019-05-14 | Cytarabine High Dose | null | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100491904 |
| 240002696 | 240005335 | 1.73 | null | Curative (C) | null | 2016-08-26 | null | null | null | ALL UKALL2011 IND A | 101135032 |
| 240002697 | 240005336 | 1.75 | 119.2 | Curative (C) | null | 2017-10-25 | AML Downs AI | null | null | TRANSPLANT ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | 100451551 |
| 240002698 | 240005337 | 1.63 | 52.6 | Curative (C) | null | 2018-02-10 | null | null | N | AML MYECHILD 01 FLA-IDARUBICIN | 100763372 |
| 240002699 | 240005338 | 1.62 | 96.8 | Curative (C) | null | 2016-05-16 | null | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 101683139 |
| 240002700 | 240005339 | null | 77.6 | 03 | 2019-06-26 | 2019-07-10 | AML MyeChild | 02 | N | ALL INT GDE 2019 MAINTENANCE | 101210916 |
| 240002704 | 240005343 | 1.79 | 106 | Curative (C) | 2019-02-13 | 2019-02-16 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | FLAIR TRIAL | 101247286 |
| 240002705 | 240005344 | 1.76 | 81.4 | Curative (C) | null | 2017-08-18 | CISPLATIN + GEMCITABINE + RITUXIMAB | null | null | FLAIR TRIAL | 100174880 |
| 240002706 | 240005345 | 1.77 | 76 | null | 2022-02-18 | 2022-02-25 | Cytarabine High Dose | 01 | null | ALEMTUZUMAB + CYTARABINE + ETOPOSIDE + FLUDARABINE + LOMUSTINE + MELPHALAN | 100290092 |
| 240002707 | 240005346 | 1.69 | 27.1 | Curative (C) | 2017-04-11 | 2017-04-15 | null | 02 | N | IBRUTINIB | 100472466 |
| 240002708 | 240005347 | 1.76 | 54.6 | null | 2020-10-10 | 2020-10-10 | null | 02 | N | FCR | 100556069 |
| 240002709 | 240005348 | 1.62 | 15.85 | null | 2019-08-15 | 2019-08-16 | null | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100279702 |
| 240002710 | 240005349 | 1.84 | 78 | null | 2019-06-17 | 2019-06-25 | FCR Oral - Cycle 1 | 02 | null | CISPLATIN + GEMCITABINE | 100363568 |
| 240002711 | 240005350 | 0 | 32.05 | Curative (C) | 2016-04-29 | 2016-04-29 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100108939 |
| 240002712 | 240005351 | 1.61 | 90 | 03 | null | 2017-02-07 | CVP R | null | null | DA | 101508381 |
| 240002713 | 240005352 | null | 74 | null | 2019-03-10 | 2019-03-10 | Imatinib 400mg | 02 | null | IMATINIB | 101505629 |
| 240002715 | 240005354 | 1.75 | 46.5 | null | 2017-11-08 | 2017-11-08 | GEMTUZUMAB OZOGAMICIN | 02 | null | RITUXIMAB + VENETOCLAX | 100309500 |
| 240002717 | 240005356 | 1.88 | 71 | Curative (C) | 2016-09-03 | 2016-11-22 | Venetoclax | 02 | N | DABRAFENIB + TRAMETINIB | 100375542 |
| 240002719 | 240005358 | 1.64 | 75.4 | Disease modification (D) | 2018-03-03 | 2018-03-04 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | QUIZARTINIB | 101330307 |
| 240002720 | 240005359 | 1.63 | 89.8 | null | 2018-10-24 | 2018-12-02 | Venetoclax | N | null | IBRUTINIB | 100130048 |
| 240002722 | 240005360 | 0 | 71.1 | Curative (C) | 2018-01-12 | 2018-01-13 | null | 02 | N | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100415407 |
| 240002723 | 240005361 | 0 | 29.9 | null | 2018-05-06 | 2018-05-09 | ATG + Busulfan + Fludarabine | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100079064 |
| 240002724 | 240005362 | 1.72 | 116.7 | null | 2016-09-30 | 2016-12-24 | null | null | null | AML MYECHILD 01 FLA-IDARUBICIN | 101660295 |
| 240002725 | 240005363 | 0 | null | null | 2017-01-16 | 2017-01-17 | TRANSPLANT BEAM | 02 | null | AML MYECHILD 01 FLA | 101098146 |
| 240002727 | 240005364 | 1.76 | 14.6 | Curative (C) | 2018-06-01 | 2018-06-02 | R IVAC | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101854468 |
| 240002728 | 240005365 | null | 32.4 | 03 | 2019-03-27 | 2019-03-29 | HD EuroNet-PHL-C1 COPDAC | 02 | null | CYCLOPHOSPHAMIDE HIGH DOSE | 100726251 |
| 240002729 | 240005366 | 1.7 | 83.4 | null | 2020-02-29 | 2020-02-29 | DA 3 + 10 | 02 | null | QUIZARTINIB | 101464129 |
| 240002731 | 240005368 | 1.52 | 72.2 | null | null | 2018-07-04 | Ibrutinib + Rituximab | 2 | null | AML MYECHILD 01 IT CYT | 100882868 |
| 240002734 | 240005371 | 1.81 | 54.3 | Palliative (P) | null | 2019-08-18 | AML Interim Guidelines FLAG-Ida | null | N | NILOTINIB | 100505346 |
| 240002735 | 240005372 | 0 | 19.45 | null | 2019-05-05 | 2019-06-27 | null | null | null | BUSULFAN | 100819675 |
| 240002737 | 240005373 | 1.62 | 55.3 | Palliative (P) | 2018-12-28 | 2018-12-30 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE | 100926406 |
| 240002739 | 240005374 | 1.57 | 39 | null | 2019-05-25 | 2019-06-19 | null | 02 | null | GEMTUZUMAB OZOGAMICIN | 100407138 |
| 240002742 | 240005377 | 1.73 | 67.4 | null | null | 2017-10-04 | Alemtuz+Fludara+Melphalan RIC MUD | null | null | BUSULFAN | 101149829 |
| 240002743 | 240005378 | 1.88 | 66.7 | 03 | 2020-01-11 | 2020-01-14 | null | 02 | N | TRABECTEDIN | 100930548 |